BIBLIOTECA - BIBLIOGRAFÍA SFC/EM

BIBLIOGRAFÍA

En esta sección figuran las publicaciones más destacadas que abordan algún aspecto referente a la clínica, investigación, discapacidad e incapacidad de la Encefalomielitis Miálgica / Síndrome de Fatiga Crónica (EM/SFC). Esta recopilación ha sido seleccionada por el equipo de expertos que forman parte del Comité Científico de CONFESQ,

AÑO 2024

• Ruiz-Pablos, M., Paiva, B., Zabaleta, A. (2024). Hypocortisolemic ASIA: a vaccine- and chronic infection-induced syndrome behind the origin of long COVID and myalgic encephalomyelitis 
• Alexander Bizjak, D., Ohmayer, B., Leonike Buhl, J., Marion Schneider, E, Walther, P., Calzia, E., Jerg, A., Matits, L., Michael Steinacker, J. (2024)  Functional and Morphological Differences of Muscle Mitochondria in Chronic Fatigue Syndrome and Post-COVID Syndrome
• José Alegre Martín (2020-2024). Disfunción autonómica y ritmo circadiano en el Síndrome de Fatiga Crónica/Encefalomielitis Miálgica: nuevas herramientas diagnósticas y terapéuticas en la enfermedad. 
• Yang, S., Tian, M., Dai, Y., Wang, R., Yamada, S., Feng, S., Wang, S., Chhangani, D., Ou, T., Johnson, A. (2024). Infection and chronic disease activate a systemic brain-muscle signaling axis 

AÑO 2023

• Esteban Carrillo Uguña, M., Michelle Orellana Romero, P. Encefalomielitis miálgica/síndrome de fatiga crónica como complicación del síndrome post-agudo de COVID-19 en adultos. Revisión bibliográfica
• Joan Carles Domingo, Federica Battistini, Begoña Cordobilla et al. (2023). Association of circulating biomarkers with illness severity measures differentiates myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID-19 condition: a prospective cohort study. Research Square.
• Mantle, D., Hargreaves, I.P., Domingo, J.C., & Castro-Marrero, J. (2023). Mitochondrial Dysfunction and Coenzyme Q10 Supplementation in Post-Viral Fatigue Syndrome: An Overview. Preprints.
• L. Grach, S., Seltzer, J., Y. Chon, T., Ganesh, R. (2023). Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. 

AÑO 2022

• Kodali, B. S. s.f.. (2022). “PETCO2 and Cardiac outputcapnography”. Educational Website CAPNOGRAPHY.

• Workwell Foundation. (2022). “Pruebas Discapacidad”. Workwell Foundation.
• Giovanni R., Lorusso, L., (2022)  Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Diagnosis and Treatment 
• Oter-Quintana, C., Esteban-Hernández, J., Cuéllar-Pompa, L., Candelas Gil-Carballo, M., Ruimán Brito-Brito, Pedro., Martín-García, A., Alcolea-Cosín, M.T., Martínez Marcos, M., Alameda-Cuesta, A. (2022) Nursing Diagnoses of Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Research Protocol for a Qualitative Synthesis
• Jason LA, Yoo S, Bhatia S. (2022) Patient perceptions of infectious illnesses preceding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

 

AÑO 2021

• CDC EE.UU. – Centers for Disease Control and Prevention EE.UU. (2021). “Información para profesionales sanitarios”. CDC EE.UU.

• CDC EE.UU. – Centers for Disease Control and Prevention EE.UU.(2021). “El estrés afecta el equilibrio químico del cuerpo”. CDC EE.UU.

• CDC EE.UU. – Centers for Disease Control and Prevention EE.UU.(2021). “Etiología y Fisiopatología EM/SFC”. CDC EE.UU.

• CDC EE.UU. – Centers for Disease Control and Prevention EE.UU.(2021). “Predisposición Genética”. CDC EE.UU.

• CDC EE.UU. – Centers for Disease Control and Prevention EE.UU.(2021). “Presentación y evolución clínica de la EM/SFC”. CDC EE.UU.

• CDC EE.UU. – Centers for Disease Control and Prevention EE.UU.(2021). “Understandig Hisory of Case and Criteria”. CDC EE.UU.

• NIH – National Institute of Heald EE.UU. (2017). “Definición ME/CFS del Grupo de Trabajo TRANS-NIH ME/CFS”. NIH.
• Sociedad estadounidense de EM/SFC. (2021). “¿Cuántas Personas tienen EM/SFC?”. American Myalgic Encephalomyelitis and Chronic Fatigue Syndrome Society.
• Ruiz-Pablos, M., Paiva, B., Montero-Mateo, R., García, N., Zabaleta, A. (2021). Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome. 
• Fluge, O., Tronstad, K., Mella, O. (2021). Pathomechanisms and possible interventions in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
• De Bellis A, Bellastella G, Pernice V, Cirillo P, Longo M, Maio A, Scappaticcio L, Maiorino MI, Bellastella A, Esposito K, Montoya JG. (2021) Hypothalamic-Pituitary Autoimmunity and Related Impairment of Hormone Secretions in Chronic Fatigue Syndrome.
• Freitag, H.; Szklarski, M.; Lorenz, S.; Sotzny, F.; Bauer, S.; Philippe, A.; Kedor, C.; Grabowski, P.; Lange, T.; Riemekasten, G. (2021) Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
• Lee JS, Lacerda EM, Nacul L, Kingdon CC, Norris J, O’Boyle S, Roberts CH, Palla L, Riley EM, Cliff JM. (2021). Salivary DNA Loads for Human Herpesviruses 6 and 7 Are Correlated With Disease Phenotype in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
• Domingues TD, Grabowska AD, Lee JS, Ameijeiras-Alonso J, Westermeier F, Scheibenbogen C, Cliff JM, Nacul L, Lacerda EM, Mouriño H, Sepúlveda N. (2021).  Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank. 
• O’Neal AJ, Hanson MR.  (2021). The Enterovirus Theory of Disease Etiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Critical Review.
• Hajdarevic R, Lande A, Rekeland I, Rydland A, Strand EB, Sosa DD, Creary LE, Mella O, Egeland T, Saugstad OD, Fluge Ø, Lie BA, Viken MK. (2021). Fine mapping of the major histocompatibility complex (MHC) in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests involvement of both HLA class I and class II loci. 
• Raanes EFW, Stiles TC. (2021). Associations Between Psychological and Immunological Variables in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Systematic Review.
• Du Preez S, Eaton-Fitch N, Cabanas H, Staines D, Marshall-Gradisnik S. (2021). Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP₂ in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
• Jason LA, Cotler J, Islam MF, Sunnquist M, Katz BZ. (2021). Risks for Developing Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in College Students Following Infectious Mononucleosis: A Prospective Cohort Study.
• Van Oosterwijck J, Marusic U, De Wandele I, Meeus M, Paul L, Lambrecht L, Moorkens G, Danneels L, Nijs J. (2021).  Reduced Parasympathetic Reactivation during Recovery from Exercise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
• Murga Gandasegui I, Aranburu Laka L, Gargiulo PÁ, Gómez-Esteban JC, Lafuente Sánchez JV. (2021). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Neurological Entity? Medicina (Kaunas). 
• Nelson T, Zhang LX, Guo H, Nacul L, Song X. (2021). Brainstem Abnormalities in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Scoping Review and Evaluation of Magnetic Resonance Imaging Findings.
• Li X, Julin P, Li TQ. (2021). Limbic Perfusion Is Reduced in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). 
• Truzzi GM, Teixeira IL, do Prado LBF, do Prado GF, Tufik S, Coelho FM. (2021). Sleep state misperception: is there a CNS structural source? 
• Brown SI. (2021). Graded exercise therapy for ME/CFS: finding consensus between the royal colleges, patients, and researchers. 
• Antcliff D, Keenan AM, Keeley P, Woby S, McGowan L. (2021).  Testing a newly developed activity pacing framework for chronic pain/fatigue: a feasibility study. 
• Natelson BH, Brunjes DL, Mancini D. (2021).  Chronic Fatigue Syndrome and Cardiovascular Disease: JACC State-of-the-Art Review. 
• Nelson MJ, Buckley JD, Thomson RL, Bellenger CR, Davison K. (2021). Markers of Cardiac Autonomic Function During Consecutive Day Peak Exercise Tests in People With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
• Monzón-Nomdedeu MB, Morten KJ, Oltra E. Induced pluripotent stem cells as suitable sensors for fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome. 

AÑO 2020

• Davenport, Todd E., Stevens, Staci R.,  Stevens, Jared,  Snell, Christopher R., Van Ness, J. Mark. (2020). “Propiedades de las mediciones obtenidas durante la prueba de esfuerzo cardiopulmonar en personas con encefalomielitis miálgica / síndrome de fatiga crónic”. IOS Press Content Library, Volumen 66, Número 2, 247-256.

• Mateo, LJ, Chu, L., Stevens, S., Stevens, J., Snell, CR, Davenport, T. y VanNess, J.M. (2020). “Post-exertional symptoms distinguish Myalgic CiteEncephalomyelitis/Chronic Fatigue Syndrome subjects from healthy. Controls”. Work (Reading, Mass.), 66 (2), 265-275.

• National Institute of Neurology Disorders and Stroke s.f. (2020). “Wechler Memory Scale IV (4ª Ed)”. National Institute of Neurology Disorders and Stroke. Revisado el 6 de junio de 2020.

• Van Campen, C., Rowe, P. C., & Visser, F. C. . (2020). “Two-Day Cardiopulmonary Exercise Testing in Females with a Severe Grade of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Comparison with Patients with Mild and Moderate Disease”. Healthcare (Basel, Switzerland), 8(3), E192.

 

AÑO 2019

• CDC EE.UU. – Centers for Disease Control and Prevention EE.UU.(2019). “What is ME/CFS, Facts and possible causes , Symptoms and Diagnosis, Information for patients and families, Treatment , ME/CFS in Children, Living with ME/CFS…”. CDC EE.UU.
• Alameda Cuesta, A., Pazos Garciandia, A., Losa Iglesias, M.E. (2019). Fibromyalgia, Chronic Fatigue Syndrome, and Multiple Chemical Sensitivity: Illness Experiences. 

• Ella, A. (2019). “Decoding the 2-day Cardiopulmonary Exercise Test (CPET) in Chronic Fatigue Syndrome (ME/CFS)”. Health Rising.

• Fernández-Solà, Joaquín. (2019). “Anexo IV. Informes emitidos por médicos especialistas sobre la valoración de la incapacidad laboral en FM, EM/SFC, SQM y EHS”. CONFESQ (2019).

• García Quintana, Ana Mª. (2019). “Anexo II. Informes emitidos por médicos especialistas sobre la valoración de la incapacidad laboral en FM, EM/SFC, SQM y EHS”. CONFESQ (2019).

• Instituto Nacional de la Seguridad Social. (2019). “GUÍA de Actualización en la Valoración de Fibromialgia, Síndrome de Fatiga Crónica, Sensibilidad Química Múltiple y Electrosensibilidad. (2ª Ed.)”. Ministerio de Inclusión, Seguridad Social y Migraciones. Gobierno de España. ( Observaciones: RETIRADA POR EL INSS. Publicación que no contó con el apoyo ni de las entidades de pacientes, ni de las principales sociedades de médicos de atención hospitalaria )

• Martín, Eva Mª. (2019). “Anexo I. Informes emitidos por médicos especialistas sobre la valoración de la incapacidad laboral en FM, EM/SFC, SQM y EHS”. CONFESQ (2019).

• McManimen, S. L., Sunnquist, M. L. & Jason, L. A. (2019). “Deconstructing post-exertional malaise: An exploratory factor analysis”. Journal of Health Psychology. 24 (2), 188–198.

• Nelson, M. J., Buckley, J. D., Thomson, R. L., Clark, D., Kwiatek, R., & Davison, K. (2019). “Diagnostic sensitivity of 2-day cardiopulmonary exercise testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome”. Journal of Translational Medicine, 17 (1), 80.

• Segovia, J.C. y López-Silvarrey, F.J. (2019). “Anexo III. Informes emitidos por médicos especialistas sobre la valoración de la incapacidad laboral en FM, EM/SFC, SQM y EHS”. CONFESQ (2019).

• Workwell Fundation. (2019). “Resources”. Workwell Fundation.

 

AÑO 2018

• Armstrong, C.W. (2018). “Some notes on included works: some notes on this document”. Open Medicine Foundation (OMF).

• Castro-Marrero, J., Zaragozá, M. C., Domingo, J. C., Martinez-Martinez, A., Alegre, J., & von Schacky, C. (2018). “Low omega-3 index and polyunsaturated fatty acid status in patients with chronic fatigue syndrome/myalgic encephalomyelitis”. Prostaglandins, Leukotrienes and Essential Fatty Acids, 139, 20-24.

• Chu, L., Valencia, I. J., Garvert, D. W. & Montoya, J. G. (2018). “Deconstructing post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: A patient-centered, cross-sectional survey”. 13 (6), e0197811.

• Fernández-Solà, J. (2018). “Acontecimienteos ambientales previos. Factores de riesgo SFC”. Hospital Clinic de Barcelona, Unidad de Síndromes de Sensibilización Central.
• García Juez, Susana. Escuela de Fisioterapia de la ONCE. (2018). “Evaluación de la respuesta al ejercicio en el SFC/EM”. ClinicalTrials.gov.

• Geraghty, K. J & Blease C. R. (2018). “Cognitive behavioural therapy in the treatment of chronic fatigue syndrome: A narrative review on efficacy and informed consent”. Journal of Health Psychology, 23 (1), 127-138.

• Geraghty, K. J. & Blease C. R. (2018). “Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and the Biopsychosocial Model: A Review of Patient Harm and Distress in the Medical Encounter”. Disability & Rehabilitation, 41(25), 3092-3102.

• Hodges, L. D., Nielsen, T. & Baken, D. (2018). “Physiological measures in participants with chronic fatigue syndrome, multiple sclerosis and healthy controls following repeated exercise: a pilot study”. Clinical Physiology and Functional Imaging, 38 (4), 639–644.

• A, Monro, B.K., Puri. (2018). “Un enfoque neurobiológico molecular para comprender la etiología del SFC (EM o enfermedad de intolerancia al esfuerzo sistémico) con implicaciones del tratamiento”. Molecular Neurobiology, 55, 7377–7388.

• Jason, L.A, Holtzman, C. S., Sunnquist, M. & Cotler, J. (2018). “The development of an instrument to assess post-exertional malaise in patients with myalgic encephalomyelitis and chronic fatigue syndrome”. Journal of Health Psychology: 1359105318805819.

• Mark Vink, M., Vink-Niese, A. (2018). “Graded exercise therapy for myalgic encephalomyelitis/chronic fatigue syndrome is not effective and unsafe. Re-analysis of a Cochrane review”. Health Psychology Open, 5 (2), 1–12.

• Monro, J.A., Puri, B.K. (2018). “Un enfoque neurobiológico molecular para comprender la etiología del SFC (EM o enfermedad de intolerancia al esfuerzo sistémico) con implicaciones del tratamiento”. Molecular Neurobiology, 55, 7377–7388 (2018).

• NINDS CDE (2018). “Project Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)”. Post Exertional Malaise Subgroup.

• OMS (2018). “Edición electrónica de la CIE-10-ES”. Ministerio de Sanidad, Consumo y Bienestar Social.

• Stevens, S., Snell, C., Stevens, J., Keller, B. & VanNess, J. M. (2018). “Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome”. Frontiers in Pediatrics, 6, 242.

• Twisk, F. N. M. (2018). “Myalgic Encephalomyelitis, chronic fatigue syndrome, and Systemic Exertion Intolerance Disease: Three distinct clinical entities”. Challenges, 9, 19.

• UK Parlament (2018). “ME: Treatment and Research”. UK Parlament, House of Commons, Westminster Hall, Volume 643 21 Jun 2018.

• VanNess, J. M., Snell, C. R., Davenpor, T. E. & Steven, S. (2018). “Opposition to Graded Exercise Therapy (GET) for ME/CFS”. Workwell Foundation.

• Vastag, V. (2018). “Prudential Insurance Company Of America”. Tribunal de Distrito de los Estados Unidos para el Distrito de Nueva Jersey.

 

AÑO 2017

• Geraghty, K. J. (2017). “Further commentary on the PACE trial: Biased methods and unreliable outcomes”. Journal of Health Psychology, 22 (9). 1209–1216.

• Geraghty, K. J. (2017). “PACE-Gate: When clinical trial evidence meets open data Access”. Journal of Health Psychology, 22 (9), 1106–1112.

• Goudsmit, E. & HowesFirst, S. (2017). “Bias, misleading information and lack of respect for alternative views have distorted perceptions of myalgic encephalomyelitis/chronic fatigue syndrome and its treatment”. Journal of Health Psychology 22 (9), 1159–1167.

• Guazzi, M., Bandera, F., Ozemek, C., Systrom, D., & Arena, R. (2017). “Cardiopulmonary Exercise Testing: What Is its Value?”. Journal of the American College of Cardiology, 70(13), 1618–1636.

• (2017). “Manual de Tiempo Óptimos de Incapacidad Temporal. Cuarta Edición”. Sociedad Española de Médicos Generales y de Familia (SEMG).

• James N. & Baraniuk, M. D. (2017). “Chronic Fatigue Syndrome prevalence is grossly overestimated using Oxford criteria compared to Centers for Disease Control (Fukuda) criteria in a U.S. population study”. Fatigue, 5 (4), 215-230.

• Marks, D.F. (2017). “Special issue on the PACE Trial”. Journal of Health Psychology, 22(9):1103-1105.

• Nacul, L., Larceda, E. M. Kingdon C. C., Curram, H.& Bowman, E. W. (2017). “How have selection bias and disease misclassification undermined the validity of myalgic encephalomyelitis/chronic fatigue syndrome studies?”. Journal of Health Psychology, 24 (12), 1765-1769.

• NIH – National Institutes of Health. (2017). “Trans-NIH ME/CFS Working Group”. National Institutes of Health (NIH).

• Racaniello, V. (2017). “Trial by Error: Retired PACE Investigator Peter White and Swiss”. Virology Blog.

• Spandler PhD, H. & Allen, M. (2017). “Contesting the psychiatric framing of ME/CFS”. Social Theory & Health, 16 (2), 127–141.

• Tuller, D. (2017). “Los CDC eliminan del sitio web la referencia a las terapias de EM/SFC en disputa”. Undark.

• Wilshire, C., Kindlon, T., Matthees, A. & McGrath, S. (2017). “Can patients with chronic fatigue syndrome really recover after graded exercise or cognitive behavioural therapy? A critical commentary and preliminary re-analysis of the PACE trial”. Fatigue: Biomedicine, Fatigue & Behavior, 5 (1), 43-56.

 

AÑO 2016

• Blease C, Carel H. & Geraghty, K. (2016). “Epistemic injustice in healthcare encounters: evidence from chronic fatigue síndrome”. Journal of Medical Ethics, 43 (8), 549–557.

• CIE-10-ES. (2016). “Volumen I: Diagnósticos Clasificación Internacional de Enfermedades – 10ª Revisión Modificación Clínica 1ª Edición”. Información y Estadísticas Sanitarias 2016. Ministerio de Sanidad, Servicios Sociales e Igualdad. Serie: Información y Estadísticas Sanitarias.

• Faro, Mònica; Sàez-Francás, Naia ; Castro-Marrero, Jesús; Aliste, Luisa; Fernández de Sevilla, Tomás; Alegre, José. (2016). “Diferencias de género en el síndrome de fatiga crónica”. Reumatología Clínica Vol. 12. Edición 2. Pág. 72-77.

• Faulkner, G. (2016). “In the Expectation of Recovery”. Misleading Medical Research an Welfare Reform. The Centre for Welfare Reform.

• Friedberg, F. (2016). “Cognitive-behavioral therapy: why is it so villified in the chronic fatigue syndrome community?”. Fatigue: Biomedicine, Health & Behavior, 4 (3), 127-131.

• Geraghty, K. J. & Esmail, A. (2016). “Chronic fatigue syndrome: is the biopsychosocial model responsible for patient dissatisfaction and harm?”. British Journal of General Practice, 66 (649), 437-438.

• Guazzi, M., Arena, R., Halle, M., Piepoli, M. F., Myers, J. & Lavie, C.J. (2016). “2016 Focused Update: Clinical Recommendations for Cardiopulmonary Exercise Testing Data Assessment in Specifc Patient Populations. EACPR/AHA Scientifc Statement”. Circulation, 133 (24), 694-711.

• Hopker, JG, Caporaso, G., Azzalin, A., Carpenter, R. y Marcora, SM. (2016). “Locomotor muscle fatigue does not alter oxygen uptake kinetics during high-intensity exercise”. Frontiers in Fisiology , 7 , 463.

• Jason, L. A., McManimen, S., Sunnquist, M., Brown, A., Furst, J., Newton, J. L. & Strand, E. B. (2016). “Case definitions integrating empiric and consensus perspectives”. Fatigue: Biomedicine, Health & Behavior. 4 (1), 1–23.

• McCook, A. (2016). “UK tribunal orders release of data from controversial chronic fatigue syndrome study”. In Retraction Watch.

• Ministerio de Sanidad, Consumo y Bienestar Social. (2016). “Proyecto de Transición CIE-9-MC a CIE-10-ES”. Ministerio de Sanidad, Consumo y Bienestar Social.

• Rebecca Walwyn 1, Laura Potts, Paul McCrone, Anthony L Johnson, Julia C DeCesare, Hannah Baber, Kimberley Goldsmith, Michael Sharpe, Trudie Chalder, Peter D White. (2016). “PACE trial”. Queen Mary University of London – QMUL.

• Ronald W. Davis, PhD, Jonathan C.W. Edwards, MD, Leonard A. Jason, PhD, Bruce Levin, PhD, Vincent R. Racaniello, PhD, Arthur L. Reingold, MD, Dharam V. Ablashi, DVM, MS, Dip Bact, James N. Baraniuk, MD, Lisa F. Barcellos, PhD, MPH, Lucinda Bateman, MD, David S. Bell, MD, Alison C. Bested MD FRCPC, Gordon Broderick, PhD, John Chia, MD, Lily Chu, MD, MSHS, Derek Enlander, MD, MRCS, LRCP, Mary Ann Fletcher, PhD, Kenneth Friedman, PhD, David L. Kaufman, MD, Nancy Klimas, MD, Charles W. Lapp, MD, Susan Levine, MD, Alan R. Light, PhD, Sonya Marshall-Gradisnik, PhD, Peter G. Medveczky, MD, Zaher Nahle, PhD, MPA, James M. Oleske, MD, MPH, Francois-Xavier Bagnoud, Richard N. Podell, M.D., MPH, Charles Shepherd, MB, BS, Christopher R. Snell, PhD, Nigel Speight, MA, MB, BChir, FRCP, FRCPCH, DCH, Donald Staines, MBBS MPH FAFPHM FAFOEM, Philip B. Stark, PhD, Eleanor Stein, MD FRCP(C), John Swartzberg, MD, Ronald G. Tompkins, MD, ScD, Rosemary Underhill, MB BS., Dr Rosamund Vallings MNZM, MB BS, Michael VanElzakker, PhD, William Weir, FRCP, Marcie Zinn, PhD, Mark Zinn, MM (2016). “An open letter to The Lancet, again”. Blog Virology.

• Simone Baldovino, Antoni Montserrat Moliner, Domenica Taruscio, Erica Daina, Dario Roccatello. (2016). “Rare Diseases in Europe: from a Wide to a Local Perspective”. The Israel Medical Association Journal: IMAJ, 18(6), 359–363.

• Swift, P. (2016). “US NIH Report Calls for UK Definition of ME/CFS to be Scrapped”. The Argus Report.

• Tucker, M. E. (2016). “Postexertion ‘Crash’, not Fatigue per se, Marks Syndrome”. Medscape Medical News.

• Vicente-Herrero, M. T., Ramírez Iñiguez de la Torre, M.V., Capdevila García, L.M., Terradillos García, M.J., López-González, A.A., Aguilar Jimenez, E., & Reinoso Barbero, L. (2016). “Exposoma: un nuevo concepto en Salud Laboral y Salud Pública”. Revista de la Asociación Española de Especialistas en Medicina del Trabajo, 25(3), 176-183.

• Vink, M. (2016). “The PACE Trial Invalidates the Use of Cognitive Behavioral and Graded Exercise Therapy in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: A Review”. Journal of Neurology and Neurobiology, 2 (3).

 

AÑO 2015

• Castro-Marrero J., Cordero M. D., Segundo, M. J., Sáez-Francàs, N., Calvo, N., Román-Malo, L., Aliste, L., Fernández de Sevilla, T. & Alegre, J. (2015). “Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome?”. Antioxid Redox Signal, 22 (8), 679–685.

• Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Board on the Health of Select Populations & Institute of Medicine (2015). “Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An IOM Report on Redefining an Illness”. The National Academies of Sciences, engieneering & Medicine (JAMA), 313 (11), 1101-1102.

• Grant, S. W., Hickey, G. L., Wisely, N. A., Carlson, E. D., Hartley, R. A., Pichel, A. C., Atkinson, D., & McCollum, C. N. (2015). “Cardiopulmonary exercise testing and survival after elective abdominal aortic aneurysm repair”. British journal of Anaesthesia, 114(3), 430–436.

• Institute of Medicine (2015). “Beyond Myalgic Encephalomyelitis/Chronic Fatigye Syndrome. Redefining an Illnes. Report Guide for Clinicians”. Institute of Medicine.

• Institute of Medicine. (2015). “Diagnostic Criteria, Diagnosis, Healthcare Providers, Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome  (ME/CFS)”. Centers for Disease Control and Prevention (CDC).

• Jason, L. A., Evans, M., So, S., Scott, J. & Brown, A. (2015). “Problems in Defining Post-Exertional Malaise”. Journal of prevention & intervention in the community, 43 (1), 20–31.

• ME Association. (2015). “ME/CFS Illness Management Survey Results. No decisions about me without me”. ME Association.

 

AÑO 2014

• Arroll, M. A., Attree, E. A., O’Leary, J. M. & C. P. Dancey. (2014). “The delayed fatigue effect in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)”. Fatigue: Biomedicine, Health & Behavior, 2 (2), 57-63.

• CIE-9-MC. (2014). “CLASIFICACIÓN INTERNACIONAL DE ENFERMEDADES. Edición Electrónica. 9ª Edición”. Ministerio de Sanidad, Servicios Sociales e Igualdad. Dirección General de Salud Pública, Calidad e Innovación. Subdirección General de Información Sanitaria.

• Cockshell, S. J. & J. L. Mathias. (2014). “Cognitive functioning in people with chronic fatigue syndrome: A comparison between subjective and objective measures”. Neuropsychology, 28(3), 394-405.

• Keller, B. A., Pryor, J. L. & Giloteaux, L. (2014). “Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO₂peak indicates functional impairment”. Journal of Translational Medicine, 12, 104.

• Nijs, J., Nees, A., Paul, L., De Kooning, M., Ickmans, K., Meeus, M. & Van Oosterwijck, J. (2014). “Altered immune response to exercise in patients with chronic fatigue syndrome/myalgic encephalomyelitis: a systematic literature review”. Exercise Immunology Review, 2, 94–116.

 

AÑO 2013

• Chu, L., Sunnquist, M., So, S. & Jason, L. A. (2013). “Patient survey results for FDA drug development meeting for ME and CFS”.com., 25-26.

• Food and Drug Administration (2013). “The voice of the patient: Chronic fatigue syndrome and myalgic encephalomyelitis”. Center for Drug Evaluation and Research (CDER), FDA.

• Jason, L. A., Brown, A., Evans, M., Sunnquist, M. & Newton, J. L. (2013). “Contrasting chronic fatigue syndrome versus myalgic encephalomyelitis/chronic fatigue syndrome”. Fatigue, 1 (3), 168-183.

• Johnston, S., Brenu, E. W., Staines, D. & Marshall-Gradisnik, S. (2013). “La prevalencia del síndrome de fatiga crónica / encefalomielitis miálgica: un metanálisis”. Clinical Epidemiology., 5 (1), 105-110.

• Loy, B. D., O’Connor, P. J. & Dishman, R. K. (2013). “The effect of a single bout of exercise on energy and fatigue states: a systematic review and meta-analysis”. Fatigue: Biomedicine, Health & Behavior, 1 (4), 223–242.

• Meyer, J.D., Light, A. R., Shukla, S. K., Clevidence, D., Yale, S., Stegner, A. J. & Cook, D. B. (2013). “Post-exertion malaise in chronic fatigue syndrome: symptoms and gene expression”. Fatigue: Biomedicine, Health & Behavior, 1 (4), 190–209.

• Snell, C. R., Stevens, S. R., Davenport, T. E. & Van Ness, J. M. (2013). “Discriminative Validity of Metabolic and Workload Measurements for Identifying People With Chronic Fatigue Syndrome”. Physical Therapy, 93 (11), 1484–1492.

• Villar Bello, Raquel, NYHA. (2013). “Escala NYHA (New York Heart Association)”. New York Heart Association – NYHA s.f.., Medicina Interna. CHU Juan Canalejo. A Coruña.

 

AÑO 2012

• Booth, N.E., Myhill, S. & McLaren-Howard, J. (2012). “Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)”. International journal of clinical and experimental medicine, 5(3), 208–220.

• Cook, D. B., Stegner, A. J., Nagelkirk, P. R., Meyer, J. D., Togo, F. & Natelson, B. H. (2012). “Responses to exercise differ for chronic fatigue syndrome patients with fbromyalgia”. Medicine and Science in Sports and Exercise, 44 (6), 1186-1193.

• Frith, J., Zalewski, P., Klawe, J.J., Pairman, J., Bitner, A., Tafil-Klawe, M., et al. (2012). “Variabilidad de la presión arterial deteriorada en el síndrome de fatiga crónica: un biomarcador potencial”. QJM. 105 (9), 831-838.

• Guazzi, M., Adams, V., Conraads, V., Halle, M., Mezzani, A., Vanhees, L., Arena, R., Fletcher, G. F., Forman, D. E., Kitzman, D. W., Lavie, C. J., Myers, J., European Association for Cardiovascular Prevention & Rehabilitation, & American Heart Association. EACPR/AHA Scientific Statement. (2012). “Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations”. Circulation, 126(18), 2261–2274.

• Instituto Nacional de la Seguridad Social. (2012). “Protocolo de actuación para médicos del INSS. Fibromialgia, Síndrome de fatiga crónica y Sensibilidad química múltiples”. Ministerio de Empleo y Seguridad Social. (Versión 1: Está desfasado, pues la evidencia científica actual, para todas las patologías descritas, muestra un paradigma bastante diferente a lo reflejado en este Protocolo. En 2019 el INSS sacó una Versión 2, que fue retirada al no contar con el respaldo ni de gran parte de la comunidad científica ni de las organizaciones de pacientes, por estar desactualizada e incluir recomendaciones muy perjudiciales para los pacientes, no basadas en la evidencia científica).

• Jones, D. E. J., Hollingsworth K. G, Jakovljevic, D G, Fattakhova, G., Pairman, J., Blamire, A. M., et al. (2012). “Pérdida de la capacidad para recuperarse de la acidosis con el ejercicio repetido en el síndrome de fatiga crónica: un estudio de casos y controles”. European Journal of Clinical Investigation, 42 (2), 186–194.

• Nijs, J., Meeus, M., Heins, M., Knoop, H., Moorkensm G. & Bleijenberg, G. (2012). “Kinesiophobia, catastrofismo y síntomas anticipados antes de subir escaleras en el síndrome de fatiga crónica: un estudio experimental”. Disability & Rehabilitation, 34 (15), 1299–1305.

• Ocon, A. J., Messer, Z.R., Medow, M.S., & Stewart, J. M. (2012). “Increasing orthostatic stress impairs neurocognitive functioning in chronic fatigue syndrome with postural tachycardia syndrome”. Clinical Science, 122 (5), 227-238.

• Wild, C. P. (2012). “The exposome: from concept to utility”. International Journal of Epidemiology, 41 (1)24–32.

 

AÑO 2011

• Arena, R., & Sietsema, K. E. (2011). “Cardiopulmonary exercise testing in the clinical evaluation of patients with heart and lung disease”. Circulation, 123(6), 668–680.

• Barnden, L. R., Crouch, B., Kwiatek, R., Burnet, R., Mernone, A., Chryssidis, S., et. al. (2011). “Un estudio de resonancia magnética cerebral del síndrome de fatiga crónica: evidencia de disfunción del tronco cerebral y homeostasis alterada”. NMR in Biomedicine, 24, (10), 1302-1312.

• Carruthers, B. M., van de Sande, M. I., De Meirleir, K. L., Klimas, N. G., Broderick, G., Mitchell, T., Staines, D., Powles, A. C., Speight, N., Vallings, R., Bateman, L., Baumgarten-Austrheim, B., Bell, D. S., Carlo-Stella, N., Chia, J., Darragh, A., Jo, D., Lewis, D., Light, A. R., Marshall-Gradisnik, S., … Stevens, S. . (2011). “(ICC 2011) Myalgic encephalomyelitis: International Consensus Criteria”. Journal of Internal Medicine, 270(4), 327–338.

• Davenport, T. E., Stevens, S. R., Baroni, K., Van Ness, J. M., & Snell. C. R. (2011). “Reliability and validity of Short Form 36 version 2 to measure health perceptions in a sub-group of individuals with fatigue”. Disability & Rehabilitation, 33 (25-26), 2596-2604.

• Davenport, T. E., Stevens, S.R., Baroni, K., VanNess, M. & Snell C. R. (2011). “Diagnostic accuracy of symptoms characterising chronic fatigue syndrome”. Disability & Rehabilitation, 33 (19-20), 1768-1775. https://doi.org/10.3109/09638288.2010.546936

• Jason, L. A., Brown, A, Evans, M., Anderson, V., Lerch, A., Brown, A., Hunnell, J. & Porter, N. (2011). “Measuring substantial reductions in functioning in patients with chronic fatigue syndrome”. Disability & Rehabilitation, 33 (7), 589-598.

• Jason, L. A., Porter, N., Hunnell, J., Brown, A., Rademaker, A. & Richman. J. A. (2011). “A natural history study of chronic fatigue syndrome”. Rehabilitation Psychology, 56 (1), 32- 42.

• Kinklon, Tom. (2011). “Daños asociados a Terapia Cognitivo Conductual y Ejercicio Gradual”. Boletín de la

• Light, A. R., Bateman, L., Jo, D., Hughen, R. W., VanHaitsma, T. A., White, A. T. & Light, K. C. (2011). “Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome”. Journal of Internal Medicine, 271 (1), 64–81.

• Nacul, L. C., Lacerda, E. M., Pheby, D., Campion, P., Molokhia, M., Fayyaz, S., Leite, J. C., Poland, F., Howe, A. & and Drachler, M. L. (2011). “Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/ CFS) in three regions of England: A repeated crosssectional study in primary care”. BMC Medicine, 9, 91.

• Núñez, M., Fernández – Solà, F., Nuñez, E., Fernández-Huerta, J. M., Godás-Sieso,T. & Gómez – Gil, E. (2011). “Health-related quality of life in patients with chronic fatigue syndrome: group cognitive behavioural therapy and graded exercise versus usual treatment. A randomised controlled trial with 1 year of follow-up”. Clinical Rheumatology, 30 (3), 381-9.

• Speight, N. (2011). “Does graded exercise therapy cure ME?”. Tymes Trust Professionals Referral Panel.

• White, A. T., Light, A. R., Hughen, R. W., VanHaitsma, T. A. & Light, K. C. (2011). “Differences in Metabolite-Detecting, Adrenergic, and Immune Gene Expression After Moderate Exercise in Patients With Chronic Fatigue Syndrome, Patients With Multiple Sclerosis, and Healthy Controls”. Psychosomatic Medicine, 74 (1), 46–54.

• White, P.D., Goldsmith, K.A, Johnson, A.L. (2011). “The PACE trial in chronic fatigue syndrome – Authors’ reply”. The Lancet, 377 (9780), 1834–1835.

• White, P.D., Goldsmith, K.A., Johnson, A.L. (2011). “Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy and specialist medical care for chronic fatigue syndrome (PACE): A randomised trial”. The Lancet, 377 (9768), 823–836.

 

AÑO 2010

• Balady, G. J., Arena, R., Sietsema, K., Myers, J., Coke, L., Fletcher, G. F., Forman, D., Franklin, B., Guazzi, M., Gulati, M., Keteyian, S. J., Lavie C. J., Macko, R., Mancini, D. & Milani, R.V. (2010). “Clinician’s guide to cardiopulmonary exercise testing in adults a scientific statement from the American heart association”. Circulation, 122, 191–225.

• Forman, D. E., Myers J., Lavie C. J., Guazzi M., Celli B., Arena R. (2010). “Cardiopulmonary exercise testing: relevant but underused”. Postgraduate Medicine, 122, 68–86.

• Jason, L. A., Evans, M., Porter, N., Brown, M., Brown, A., Hunnell, J., Anderson, V., Lerch, A., De Meirleir, K. & Friedberg, F. (2010). “The development of a revised Canadian myalgic encephalomyelitis chronic fatigue syndrome case defnition”. American Journal of Biochemistry and Biotechnology, 6 (2), 120-135.

• Jason, L.A., Boulton, A., Porter, N. S., Jessen, T., Njoku, M. G. & Friedberg, F. (2010). “Classification of myalgic encephalomyelitis/chronic fatigue syndrome by types of fatigue”. Behavioral Medicine 36 (1), 24-31.

• Javierre, Casimiro; Guillamò, Elisabet; Blázquez, Alicia; Comella, Agustí; Martínez-Rodríguez, Rubén; Garrido, Eduardo; Barbany Cairó, Joan; Ventura, Josep. (2010). “Respuesta respiratoria al ejercicio físico de baja intensidad en mujeres con síndrome de fatiga crónica”. Apunts: Medicina de l’esport, Vol. 45, Núm. 167, p. 169-73.

• Jones, D. E. J., Hollingsworth, K. G., Taylor, R., Blamire, A. M. & Newton, J. L. (2010). “Las anomalías en el manejo del pH por el músculo periférico y la regulación potencial por el sistema nervioso autónomo en el síndrome de fatiga crónica”. Journal of Internal Medicine, 267 (4), 394–401.

• Kerr, J. R., Gough, J., Richards, S.C.M., Main, J., Enlander, D., McCreary, M., Komaroff, A. L. & Chia, K. (2010). “Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis”. The Journal of General Virology, 91(Pt 4), 893–897.

• Meeus, M., Roussel, N. A. & Truijen, S. (2010). “Reduced pressure pain thresholds in response to exercise in chronic fatigue syndrome but not in chronic low back pain: An experimental study”. Journal of Rehabilitation Medicine. 42(9): 884–890.

• Nijs, J., Van Oosterwijck, J., Meeus, M., Lambrecht, L., Metzger, K., Fremont, M. & Paul. L. (2010). “Unravelling the nature of postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: The role of elastase, complement C4a and interleukin-1beta”. Journal of Internal Medicine, 267 (4), 418-435.

• (2010). “G90-G99 Otros trastornos del sistema nervioso“. ICD-10 (Version: 2010).

• Van Oosterwijck, J., Nijs, J., Meeus, M., Lefever, I., Huybrechts, L., Lambrecht, L. & Paul, L. (2010). “Pain inhibition and postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: An experimental study”. Journal of Internal Medicine, 268 (3), 265–278.

• VanNess, J. M., Stevens, S. R., Bateman, L., Stiles, T. L. & Snell, C. R. (2010). “Postexertional malaise in women with chronic fatigue syndrome”. Journal of Women’s Health, 19 (2), 239- 244.

• Vermeulen, R. C., Kurk, R. M., Visser, F. C., Sluiter, W., & Scholte, H. R. (2010). “Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity”. Journal of Translational Medicine, 8 (1), 93.

• White, A. T., Light, A. R., Hughen, R. W., Bateman, L., Martins, T. B., Hill, H. R., and Light, K. C. (2010). “Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome”. Psychophysiology, 47 (4), 615-624.

• Zhang, L., Gough, J. Christmas, D. Mattey, D. L., Richards, S. C., Main, J., Enlander, D., Honeybourne, D., Ayres, J. G., Nutt, D. J. & Kerr, J. R. (2010). “Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis”. Journal of Clinical Pathology, 63 (2), 156-164.

 

AÑO 2009

• Bordas Guijarro, J., Domínguez Ponce, M.A., Vázquez Foncubierta, A., Pedrote, A., Chaves Barroso, R., Álvarez López, R. (2009). “Síndrome Tolerancia ó Taquicardia Postural Ortostática”. Revista Española de Geriatría y Gerontología, Vol. 44 Nº 6, págs. 356-357.

• Light, A. R., White, A. T., Hughen, Ronald W. & Light, K. C. (2009). “Moderate Exercise Increases Expression for Sensory, Adrenergic, and Immune Genes in Chronic Fatigue Syndrome Patients But Not in Normal Subjects”. The Journal of Pain, 10 (10), 1099–1112.

• Ministerio de Sanidad y Política Social (2009). “Estrategia en Enfermedades Raras del Sistema Nacional de Salud”. Estrategia aprobada por el Consejo Interterritorial del Sistema Nacional de Salud el 3 de junio de 2009.

• Myhill, S., Booth, N. E. & McLaren-Howard, J. (2009). “Chronic fatigue syndrome and mitochondrial dysfunction”. Int J clin Exp Med, 2, 1-16.
• Twisk, F. N. M. & Maes, M. (2009). “A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS”. Neuro Enocrinology Letters, 30 (3), 284-99.

• Valverde, C., Markez, I. y Visiers, C. (2009). “Breves intervenciones en el largo viaje: La comunicación con pacientes con Fibromialgia o síndrome de la fatiga crónica. Manual para profesionales sanitarios”.

• Valverde, C., Markez, I. y Visiers, C. (2009). “Nuevos retos en la consulta: ¿Qué hacer ante la Fibromialgia, el Síndrome de la Fatiga Crónica-EM y las Sensibilidades Químicas Múltiples? Manual de comunicación”.

• Whitehead, L. (2009). “The measurement of fatigue in chronic illness: A systematic review of unidimensional and multidimensional fatigue measures”. Journal of Pain and Symptom Management, 37 (1), 107-128.

 

AÑO 2008

• Fuller-Thomson, E, Nimigon, J (2008). “Factors associated with depression among individuals with chronic fatigue syndrome: Findings from a nationally representative survey”. Family Practice, 25 (6), 414–422.

• Joyner, M. J. & Coyle, E. F. (2008). “Endurance exercise performance: the physiology of champions”. The Journal of Physiology, 586(1), 35–44.

• Kishi, A., Struzik, Z. R, Natelson, B. H, Togo, F. & Yamamoto, Y. (2008). “Dynamics of sleep stage transitions in healthy humans and patients with chronic fatigue syndrome”. American journal of Physiology. Regulatory, integrative and comparative physiology, 294(6), R1980–R1987.

• Nijs, J., Almond, F., De Becker, P., Truijen, S. & Paul, L. (2008). “Can exercise limits prevent post-exertional malaise in chronic fatigue syndrome? An uncontrolled clinical trial”. Clinical Rehabilitation, 22 (5), 426–435.

• Pall, Martin L. (2008). “Teoría del ciclo del óxido nítrico: ¿Explicaría el SFC, la FM y otras “enfermedades inexplicadas?”. Norte de Salud Mental, nº 30, pág. 99-102.

• Togo, F., Natelson, B. H, Cherniack, N. S, FitzGibbons, J., Garcon, C. & Rapoport, D. M. (2008). “Sleep structure and sleepiness in chronic fatigue syndrome with or without coexisting fibromyalgia”. Arthritis Research & Therapy., 10, 56.

 

AÑO 2007

• Arena, R., Myers, J., Williams, M. A., Gulati, M., Kligfield, P., Balady, G. J., Collins, E., Fletcher, G., American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology, & American Heart Association Council on Cardiovascular Nursing. (2007). “Assessment of functional capacity in clinical and research settings: a scientific statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing”. Circulation, 116(3), 329–343.

• Consenso de EPOC. (2007). “Diagnóstico y clasificación de la EPOC“. Neumología y Cirugía de Tórax. Vol 66(S2):S19-S24 (2007).

• NICE – National Institute for Health and Clinical Excellence. (2007). “Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children”.

• Segovia, J.C.; López Silvarrey, F.J.; Legido, J.C. (2007). “Manual de Valoración Funcional. Aspectos Clínicos y Fisiológicos”. Madrid, Elsevier ISBN 8480862343, 9788480862349.

• Van Hoof, E., De Becker, P., Lapp, C., et al. (2007). “Defining the occurrence and influence of alph-delta sleep in chronic fatigue syndrome”. The American Journal of Medical Sciences., 333, 78-84.

• Vanness, J. M., Snell, C. R. & Stevens, S. R. (2007). “Diminished Cardiopulmonary Capacity During Post-Exertional Malaise”. Journal of Chronic Fatigue Syndrome, 14 (2), 77–85.

• White, P.D., Sharpe, M.C., Chalder, T. (2007). “Protocol for the PACE trial: A randomised controlled trial of adaptive pacing, cognitive behaviour therapy and graded exercise, as supplements to standardised specialist medical care versus standardised specialist medical care alone for patients with the chronic fatigue syndrome/myalgic encephalomyelitis or encephalopathy”. BMC Neurology, 7 (6).

• Yoshiuchi, K., Cook, B., Ohashi, K., Kumano, H., Kuboki, T.,  Yamamoto, Y. & Natelson. B. H. (2007). “A real-time assessment of the effect of exercise in chronic fatigue syndrome”. Physiology & Behavior, 92 (5), 963-968.

 

AÑO 2006

• Basset, J. (2006). “Testing for M.E. – Summary”. The Humingbirds Foundation for M.E. (HFME). Traducción Blanca Mesistrano. Asociación Fibroamérica…

• Cocine, D.B., Nagelkirk, P.R., Poluri, A., Mores, J. & Natelson, B.H. (2006). “La influencia del ejercicio aeróbico y la Fibromialgia en las respuestas cardiorrespiratorias y perceptivas al ejercicio en pacientes con síndrome de fatiga crónica”. Artritis reum. 54 (10), 3351-3362.

• De Becker, P., Roeykens, J., Reynders, M., McGregor, N., De Meirleir, K. (2006). “Exercise capacity in chronic fatigue syndrome”. Archives of Internal Medicine, 160, 3270–77.

• Hawk, C., Jason, L. A. & Torres-Harding S. (2006). “Reliability of a chronic fatigue syndrome questionnaire”. Journal of Chronic Fatigue Syndrome, 13 (4), 41-66.

• Hyde, B. (2006). “Testing For Myalgic Encephalomyelitis – Summary By Jodi Bassett”.com.

• Pardaens, K., Haagdorens, L., Van Wambeke, P., Van den Broeck, A., & Van Houdenhove, B. (2006). “How relevant are exercise capacity measures for evaluating treatment effects in chronic fatigue syndrome? Results from a prospective, multidisciplinary outcome study”. Clinical Rehabilitation, 20(1), 56–66.

 

AÑO 2005

• Bazelmans, E., Bleijenberg, G., Voeten, M. J. M., van der Meer, J. W. M. & Folgering, H. (2005). “Impact of a maximal exercise test on symptoms and activity in chronic fatigue syndrome”. Journal of Psychosomatic Research, 59 (4), 201-208.

• Schmaling, K. B., Fiedelak, J. I., Bader, J., Buchwald, D. (2005). “A longitudinal study of physical activity and body mass index among persons with unexplained chronic fatigue”. Journal of Psychosomatic Research, 58 (4), 375-81.

• Snell, C. R., Vanness, J.M., Strayer, D.R. & Stevens, S.R. (2005). “Exercise capacity and immune function in male and female patients with chronic fatigue syndrome (CFS) patients”. In vivo, 19, 387–390.

• Welsman, J., Bywater, K., Farr, C., Welford, D. & Armstrong, N. (2005). “Reliability of peak VO(2) and maximal cardiac output assessed using thoracic bioimpedance in children”. Eur J Appl Physiol, 94, 228–234.

 

AÑO 2004

• Burgess, M. & Chalder, T. (2004). “PACE manual for therapists, Version 2”. MREC Version 2 – November 2004 – ISRCTN54285094.

• European Commission Health & Consumer Protection Directorate-General. (2004). “Useful information on rare diseases from an EU perspective”. European Commission Health & Consumer Protection.

• Hansen, J. E., Sun, X. G., Yasunobu, Y., Garafano R. P., Gates, G., Barst, R. J. & Wasserman, K. (2004). “Reproducibility of cardiopulmonary exercise measure-ments in patients with pulmonary arterial hypertension”. Chest, 126, 816–824.

• Nijs, J., De Meirleir, K. & Duquet, W. (2004). “Kinesiophobia en el síndrome de fatiga crónica: evaluación y asociaciones con discapacidad”. Archives of Physical Medicine and Rehabilitation (ACRM), 85 (10), 1586-1592.

• Nijs, J., Vanherberghen, K., Duquet, W. & De Meirleir, K. (2004). “Chronic fatigue syndrome: lack of association between pain-related fear of movement and exercise capacity and disability”. Physical Therapy, 84(8), 696-705.

• Puri, B. K., Holmes, J., & Hamilton, G. (2004). “Eicosapentaenoic acid‐rich essential fatty acid supplementation in chronic fatigue syndrome associated with symptom remission and structural brain changes”. International Journal of Clinical Practice, 58 (3), 297-299.

• Puri, B.K. (2004). “The use of eicosapentaenoic acid in the treatment of chronic fatigue syndrome”. Prostaglandins, Leukotrienes and essential fatty acids, 70 (4), 399-401.

• Whiteside, A., Hansen, S. & Chaudhuri, A. (2004). “Exercise lowers pain threshold in chronic fatigue syndrome”. Pain, 109 (3), 497–499.

 

AÑO 2003

• Carruthers, B. M., Jain, A. K., De Meirleir, K. L., Peterson, D. L., Klimas, N. G., Lerner, A. M., Bested, A. C., Flor¬Henry, P., Pradip, J., Powles, A. C. P., Sherkey J. A. & Van de Sande, M. I. (2003). “Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case: Definition, Diagnostic and Treatment Protocols. A Consensus Document”. Journal of Chronic Fatigue Syndrome, 11 (1), 7¬115.

• Sorensen, B., Streib, J. , Strand, M., Make, B., Giclas, P.  C., Fleshner, M. & Jones,  J. F. (2003). “Complement activation in a model of chronic fatigue syndrome”. Journal of Allergy & Clinical Immunology, 112 (2), 397-403.

• Vanness, J. M, Snell, C. R, Strayer, D.R, Dempsey, L. & Stevens, S.R. (2003). “Subclassifying chronic fatigue syndrome through exercise testing”. Medicine and Science in Sports and Exercise, (2003) 35, 908–13.

 

AÑO 2002

• Andreacci, J. L., Lemura LM, Cohen SL, Urbansky EA, Chelland SA, Duvillard SPV. (2002). “Los efectos de la frecuencia de estímulo en el rendimiento durante las pruebas de ejercicio máximo”. Journal of Sports Sciences, 20(4), 345–352.

• Farquhar, W. B., Hunt, B. E., Taylor, J. A., Darling, S. E. & Freeman, R. (2002). “Blood volume and its relation to peak O2 consumption and physical activity in patients with chronic fatigue”. American Journal of Physiology. Heart and Circulatory Physiology, 282 (1), 66- 71.

• Jason, L. A., & Taylor, R. (2002). “Applying cluster analysis to define a typology of chronic fatigue syndrome in a medically-evaluated, random community sample”. Psychology and Health, 17 (3), 323-337.

• Mostert, S. & Kesselring, J. (2002). “Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis”. Multiple Sclerosis (Houndmills, Basingstoke, England), 8 (2), 161–168.

• Sargent, C., Scroop, G. C., Nemeth, P. M., Burnet, R. B. & Buckley, J. D. (2002). “Maximal oxygen uptake and lactate metabolism are normal in chronic fatigue syndrome”. Medicine and Science in Sports and Exercise, 34 (1), 51-56.

• Herrell, R., Goldberg, J., Hartman, S., Schmaling, K., Buchwald, D. (2002). “Chronic fatigue and chronic fatigue syndrome: A co-twin control study of functional status”.Qual Life Res 11, 463–471 (2002).

 

AÑO 2001

• Bazemans, E., Bleijenberg, G., Van Der Meer, J. W. M. & Folgering, H. (2001). “Is physical deconditioning a perpetuating factor in chronic fatigue syndrome? A controlled study on maximal exercise performance and relations with fatigue, impairment and physical activity”. Psychological Medicine, 31 (1), 107-114.

• De Becker P, Roeykens J, Reynders M, McGregor N, De Meirleir K. (2001). “Exercise capacity in chronic fatigue síndrome”. Archives of Internal Medicine, 160(21):3270-3277, Año 2000. [published correction appears in Arch Intern Med 2001 Sep 10; 161(16):2051-2].

• De Becker, P., McGregor, N. & De Meirleir, K. (2001). “A defnition-based analysis of symptoms in a large cohort of patients with chronic fatigue syndrome”. Journal of Internal Medicine, 250 (3), 234-240.

• Dunn, A. L., Trivedi, M. H. & O’Neal, H. A. (2001). “Physical activity dose-response effects on outcomes of depression and anxiety”. Medicine and Science in Sports and Exercise, 33 (6), 609–610.

• Hollmann, W. (2001). “42 years ago–development of the concepts of ventilatory and lactate threshold”. Sports Medicine (Auckland, N.Z.), 31(5), 315–320.

• Inbar O, Dlin R, Rotstein A, Whipp B.J. (2001). “Physiological responses to incremental exercise in patients with chronic fatigue síndrome”. Medicine and Science in Sports and Exercise, 2001; 33(9):1463-1470.

• Koufaki, P., Naish, P. F. & Mercer, T. H. (2001). “Reproducibility of exercise tolerance in patients with end-stage renal disease”. Archives of Physical Medicine and Rehabilitation (ACRM), 82(10), 1421–1424.

• Streeten DH. (2001). “Role of impaired lower-limb venous innervation in the pathogenesis of the chronic fatigue síndrome”. American Journal of Medicine 321(3):163-167, 2001.

• Tanaka, H., Monahan, K. D. & Sellos, D. R. (2001). “Revisión de la frecuencia cardíaca máxima predicha por edad”. Journal of the American College of Cardiology, 37 (1), 153-156.

 

AÑO 2000

• Instituto de Migraciones y Servicio Sociales – IMSERSO. (2000). “GUÍA de valoración de Discapacidad laboral para médicos. (1ª Ed.)”. Ministerio de Trabajo y Asuntos Sociales. Secretaria General de Asuntos Sociales. Instituto de Migraciones y Servicio Sociales. ISBN: 84- 8446-026-6.

 

AÑO 1999

• Denny, T. N., Gause, W. C. & Natelson, B. H. (1999). “Immunological response in chronic fatigue syndrome following a graded exercise test to exhaustion”. Journal of Clinical Immunology, 19(2), 135-142.

• Jason, L .A, Richman, J. A., Rademaker, A.W., Jordan, K.M., Plioplys, A.V., Taylor, R.R., McCready, W., Huang, C. & Plioplys, S. (1999). “A Community Based Study of Chronic Fatigue Syndrome”. Archives of Internal Medicine, 159 (18), 2129–2137.

• Mccully, K. K. & Natelson, B. H. (1999). “Deterioro del suministro de oxígeno al músculo en el síndrome de fatiga crónica”. Clinical Science. 97 (5), 603–608.

• McKone, E. F., Barry, S. C., FitzGerald, M. X. & Gallagher, C. G. (1999). “Reproducibility of maximal exercise ergometer testing in patients with cystic fibrosis”. Chest, 116(2), 363–368.

• Simons, D. G., Travell, J. G. & Simons, L. S. (1999). “Travell & Simons’ Myofascial Pain and Dysfunction: Upper half of body”. Lippincott Williams & Wilkins.

 

AÑO 1998

• Blackwood, S. K., MacHale, S. M., Power, M. J., Goodwin, G. M. & Lawrie, S. M. (1998). “Effects of exercise on cognitive and motor function in chronic fatigue syndrome and depression”. Journal of Neurology, Neurosurgery and Psychiatry, 65 (4), 541-546.

• De Lorenzo, F., Xiao, H., Mukherjee, M., Harcup, J., Suleiman, S., Kadziola, Z., et al. (1998). “Síndrome de fatiga crónica: descondicionamiento físico y cardiovascular”. , 91 (7), 475–481.

• Demitrack, M. A., Crofford L. J. (1998). “Evidencia e implicaciones fisiopatológicas de la desregulación del eje hipotálamo-hipófisis-suprarrenal en la Fibromialgia y el síndrome de fatiga crónica”. Annals of the New York Academy of Sciences, 840 (1), 684–697.

• Holmes, G. P., Kaplan, J. E., Gantz, N. M., Komaroff, A. L., Schonberg, L. B. & Straus, S.E. (1998). “Chronic fatigue syndrome: a working case definition”. Annals of internal Medicine, 108(3), 387–389.

• LaManca, J. J., Sisto, S. A., Zhou, X., Ottenweller, J. E., Cook, S., Peckerman, A., Zhang, Q. W., Lane, R. J, Barrett, M. C., Taylor, D. J., Kemp, G. J. & Lodi, R. (1998). “Heterogeneidad en el síndrome de fatiga crónica: evidencia de la espectroscopia de resonancia magnética del músculo”. Trastorno neuromuscular, 8 (3), 204-209.

• Morriss, R., Wearden, A. & Mullis, R. (1998). “Explorando la validez de la escala de fatiga de Chalder en el síndrome de fatiga crónica”. Journal of Psychosomatic Research, 45 (5), 411–417.

 

AÑO 1997

• Lapp, C. W. (1997). “Exercise limits in chronic fatigue syndrome“. The American Journal of Medicine, 103 (1): 83–84.

 

AÑO 1996

• Komaroff, A. L., Fagioli, L. R., Doolittle, T. H., Gandek, B., Gleit, M. A., Guerriero, R. T, Kornish I. R. J., Warem N. C., Ware, J. E. and Bates D. W. (1996). “Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups”. The American Journal of Medicine, 101 (3), 281-290.

• Komaroff, A. L., Fagioli, L. R., Geiger, A. M., Doolittle, T. H., Lee, J., Kornish, J., Gleit, M. A. & Guerriero, R. T. (1996). “An examination of the working case defnition of chronic fatigue syndrome“. American Journal of Medicine, 100 (1), 56-64.

• Lehmann, G., & Kolling, K. (1996). “Reproducibility of cardiopulmonary exercise parameters in patients with valvular heart disease”. Chest, 110, 685–692.

• Meyer, K., Westbrook, S., Schwaibold, M., Hajric, R., Peters, K. & Roskamm, H. (1996). “Short-term reproducibility of cardiopulmonary measurements during exercise testing in patients with severe chronic heart failure”. The American Journal of Cardiology, 78(9), 1017–1022.

• Samii, A., Wassermann, E., Ikoma, K., Mercuri, B., George, M., O’fallon, A., et al. (1996). “Disminución de la facilitación posterior al ejercicio de los potenciales evocados motores en pacientes con síndrome de fatiga crónica o depresión”. Neurología. 47 (6), 1410-1414.

• Sisto, SA, LaManca, J., Cordero, DL, Bergen, MT, Ellis, SP, Drastal, S. Y Natelson, BH. (1996). “Efectos metabólicos y cardiovasculares de una prueba de esfuerzo progresiva en pacientes con síndrome de fatiga crónica”. Revista estadounidense de medicina, 100 (6), 634-640.

 

AÑO 1995

• Howley, E. T., Bassett, D. R. & Welch, H. G. (1995). “Criterios para el consumo máximo de oxígeno: revisión y comentarios”. Medicine and Science in Sports and Exercise, 27 (9), 1292–1301.

• Smets, E. M., Garssen, B., Bonke, B. & De Haes, J. C. (1995). “The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue”. Journal of Psychosomatic Research, 39 (3), 315-325.

• Taylor, H. L., Buskirk, E. & Henschel, A. (1995). “Maximal oxygen intake as an objective measure of cardio-respiratory performance”. Journal of applied physiology, 8(1), 73–80.

 

AÑO 1994

• Fukuda, K., Straus, S. E., Hidkie, I., Sharpe, M. C., Dobbins, J. G. & Komaroff, A. (1994). “The Chronic Fatigue Syndrome: A comprehensive approach to its definition and study”. Annals of Internal Medicine, 12 (121),  953-959.

 

AÑO 1993

• Barnes, P., Taylor D. J., Kemp G. J. & Radda G. K. (1993). “Bioenergética del músculo esquelético en el síndrome de fatiga crónica”. Journal of Neurology, Neurosurgery & Psychiatry, 56 (6), 679–683.

• Chalder, T., G. Berelowitz, T. Pawlikowska, L. Watts, S. Wessely, D. Wright, and E. P. Wallace. (1993). “Development of a fatigue scale”. Journal of Psychosomatic Research, 37 (2), 147-153.

• Goldstein, J.A. (1993). “Chronic Fatigue Syndrome: The Limbic Hypothesis”. Haworth Medical Press, Binghampton Nueva York: Routledge, pg 116. FM Network Oct 1993, pp 10­11; ISBN 13: 9781560249047.

• E. Ware, M. Kosinski and B. Gandek. (1993). “SF-36 Health Survey: Manual and Interpretation Guide”. The Health Institute, New England Medical Center, Boston, Massachusetts.

• Marciniuk, D., Watts, R. E. & Gallagher, C. G. (1993). “Reproducibility of incremental maximal cycle ergometer testing in patients with restrictive lung disease”. Thorax, 48, 894–898.

• McHorney, C. A., Ware, J. E., & Raczek. A. E. (1993). “The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs”. Medical Care, 31 (3), 247-263.

 

AÑO 1992

• Ray, C., Weir, W. R. C., Phillips, S. & Cullen, S. (1992). “Development of a measure of symptoms in chronic fatigue syndrome: The Profle of Fatigue-Related Symptoms (PFRS)”. Psychology & Health, 7 (1), 27-43.

 

AÑO 1991

• Straus, S. E. (1991). “History of Chronic Fatigue Syndrome”. Reviews of infectious diseases, 13 Suppl 1, S2–S7.

 

AÑO 1990

• Behan, P. O., Behan, W. M., & Horrobin, D. (1990). “Effect of high doses of essential fatty acids on the postviral fatigue syndrome“. Acta Neurologica Scandinavica, 82(3), 209-216.

• Borg, G. (1990). “Escalamiento psicofísico con aplicaciones en el trabajo físico y la percepción del esfuerzo”. Scandinavian Journal of Work, Environment & Health, 16 (1), 55-8.

• Janicki, J. S, Gupta, S., Ferris, S. T. & McElroy, P. A. (1990). “Long-term reproducibility of respiratory gas Exchange measurements during exercise in patients with stable cardiac failure”. Chest, 97, 12–7.

• Weltman, A., Snead, D., Stein, P., Seip, R., Schurrer, R., Rutt, R. & Weltman, J. (1990). “Reliability and validity of a continuous incremental treadmill protocol for the determination of lactate threshold, fixed blood lactate concentrations, and VO2 max”. International journal of sports medicine, 11(1), 26–32.

 

AÑO 1989

• Krupp, L. B., LaRocca, N. G. Muir-Nash, J. & Steinberg. A. D. (1989). “The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus”. Archives of Neurology, 46(10), 1121–1123.

• Robb-Nicholson, L. C., Daltroy, L., Eaton, H., Gall, V., Wright, E., Hartley, L. H., Schur, P. H. & Liang, M. H. (1989). “Effects of aerobic conditioning in lupus fatigue: a pilot study”. British Journal of Rheumatology, 28 (6), 500–505.

 

AÑO 1986

• Beaver, W. L., Wasserman, K. & Whipp, B.J. (1986). “Un nuevo método para detectar el umbral anaeróbico por intercambio de gases”. Journal of Applied Physiology., 60 (6),2020-2027.

 

AÑO 1985

• Davis, J. A. (1985). “Anaerobic threshold: review of the concept and directions for future research”. Medicine and Science in Sports and Exercise, 17 (1), 6-21.

 

AÑO 1984

• Aunola, S. & Rusko, H. (1984). “Reproducibility ofaerobic and anaerobic thresholds in 20-50 yearold men”. European Journal of Applied Physiology and Occupational Physiology, 53, 260–66.

 

AÑO 1982

• Katch, V. L., Sady S.S. &Freedson P. (1982). “Biological variability in maximum aerobic power”. Medicine and Science in Sports and Exercise, 14(1), 21–25.

• Weber, K. T., Kinasewitz, G. T., Janicki, J. S., & Fishman, A. P. (1982). “Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure”. Circulation, 65(6), 1213–1223.

 

AÑO 1981

• Wasserman, K., Whipp, B. J. & Davis, J. A. (1981). “Respiratory physiology of exercise: metabolism, gas exchange, and ventilatory control”. International review of physiology, 23, 149–211.

 

AÑO 1980

• Skinner, J. S. & McLellan, T. H. (1980). “The transition from aerobic to anaerobic metabolism“. Research quarterly for exercise and sport, 51(1), 234–248.

 

AÑO 1973

• Bruce, R.A., Kusumi, F. & Hosmer, D. (1973). “Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease”. American Heart Journal, 85 (4), 546– 562.

 

AÑO 1959

• Acheson, E.D. (1959). “The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland disease and epidemic neuromyasthenia”. American Journal of Medicine, 26, 569–595.

 

AÑO 1958

• Mitchell, J. H., Sproule, B. J. & Chapman, C. B. (1958). “The physiological meaning of the maximal oxygen intake test”. The Journal of Clinical Investigation, 37, 538–47.

 

AÑO 1957

• Ramsay, A. M. (1957). “Encephalomyelitis in north west London; an endemic infection simulating poliomyelitis and hysteria”. Lancet, 270, 1196–1200.

 

AÑO 1956

• Acheson, E.D. (1956). “A new clinical entity?”. Lancet, 267, 789–790.

 

AÑO 1937

• Robinson, S., Edwards, H. T., Dill, D. B. (1937). “New records in human power”. Science, 85, 409– 10.